Trial Profile
A Phase I trial of Remimazolam continuous infusion assessing safety, pharmacokinetics and pharmacodynamics in the Indication General Anesthesia in Japanese Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary)
- Indications Anaesthesia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Registrational
- 02 Mar 2016 New trial record